Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
How Should AI Be Integrated Into Clinical Trial Operations?
Research & Development How Should AI Be Integrated Into Clinical Trial Operations?

Implementing a tool in the middle of a study cycle risks overwhelming staff and creating irregular data points that complicate the final analysis. As the pharmaceutical sector moves through 2026, the proliferation of artificial intelligence has moved beyond theoretical promise to a tangible

New Ultrasound and CT Fusion Improves Spine Surgery Precision
Tech & Innovation New Ultrasound and CT Fusion Improves Spine Surgery Precision

Pedicle screw placement requires sub-millimeter accuracy because a deviation of only two millimeters can cause permanent nerve damage or severe vascular injury. In the modern surgical suite, the challenge is not just the operation itself but balancing the necessity of precise visualization with the

Can Isomorphic Labs Justify a $50 Billion AI Valuation?
Tech & Innovation Can Isomorphic Labs Justify a $50 Billion AI Valuation?

With a focus on advanced machine learning, Isomorphic Labs is attempting to cut years off the timeline required to bring life-saving drugs from the lab to patients. This ambitious goal is currently being met with unprecedented investor enthusiasm, as reports indicate the Alphabet spinoff is seeking

How Is CAR-T Therapy Changing Cancer Care in Malaga?
Research & Development How Is CAR-T Therapy Changing Cancer Care in Malaga?

The traditional paradigm of treating blood cancers with chemotherapy is shifting as genetic engineering allows patients' own white blood cells to be reprogrammed as biological 'GPS' units. In the heart of Malaga, this scientific breakthrough has moved beyond the theoretical realm and into the

Can Lab-in-the-Loop AI Accelerate Modern Drug Discovery?
Tech & Innovation Can Lab-in-the-Loop AI Accelerate Modern Drug Discovery?

The era where pharmaceutical success depended on the serendipitous discovery of a blockbuster molecule has officially been eclipsed by a precision-engineered approach that treats biological research as a programmable loop. The pharmaceutical industry currently navigates a transformative era where

US Bill Aims to Ban Corporate Ownership of Medical Practices
Management & Regulatory US Bill Aims to Ban Corporate Ownership of Medical Practices

Prohibiting management services organizations from owning equity or financing physician ownership could force a massive restructuring of the current healthcare investment market. Launched in late 2026, the Stop Corporate Takeovers of Physicians Act serves as a definitive federal intervention into

The Gut-Brain Axis and Global Equity in MS Precision Medicine
Tech & Innovation The Gut-Brain Axis and Global Equity in MS Precision Medicine

The significant gender imbalance in multiple sclerosis suggests a sex-microbiota-immune axis that requires specialized analysis to develop effective personalized treatments. The scientific understanding of multiple sclerosis (MS) is currently undergoing a significant paradigm shift. Once viewed

Can AI Improve the Staging of COVID-19 Lung Infections?
Tech & Innovation Can AI Improve the Staging of COVID-19 Lung Infections?

The volumetric extent of ground-glass opacities and consolidations serves as a critical marker for determining the stage of a viral lung infection. In the high-pressure environment of intensive care, doctors must constantly decipher whether a patient is on the path to recovery or teetering on the

iRhythm Growth Tested by Significant 2026 Cybersecurity Breach
Management & Regulatory iRhythm Growth Tested by Significant 2026 Cybersecurity Breach

A gross margin expansion to 72.8% in the second quarter of 2026 demonstrated iRhythm's operational scaling just as a significant cybersecurity crisis unfolded. The intersection of these two events creates a paradox for the digital healthcare giant, which has seen its Zio platform achieve

ZETA and BeneMeat Partner to Scale Up Cultivated Meat
Management & Regulatory ZETA and BeneMeat Partner to Scale Up Cultivated Meat

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later